By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Lonza Group Ltd. 

Muenchensteinerstrasse 38

Basel    CH-4002  Switzerland
Phone: 0041-61-316-8363 Fax: 0041-61-316-8820


SEARCH JOBS


Industry
Pharmaceutical






Company News
Lonza Group (LZAGY.PK) Release: Low Endotoxin Recovery (LER) White Paper Released To QC Insider Toolbox 3/7/2017 9:26:33 AM
Sanofi (SNY), Lonza Group (LZAGY.PK) Partner Up to Build New $285 Million Swiss Biologics Facility 2/27/2017 5:46:01 AM
Lonza Group (LZAGY.PK) Successfully Places 5.0 Million New Shares, Raising Gross Proceeds Of CHF 865 Million 2/1/2017 7:09:53 AM
Lonza Group (LZAGY.PK) Release: Company Reports Record-Breaking Financial Performance, Resulting In 24.2% CORE EBIT Growth, Driven By Pharma&Biotech 1/25/2017 11:18:34 AM
Lonza Group (LZAGY.PK) Release: Company Appoints Fridtjof Helemann, CHRO, to Executive Committee 1/25/2017 10:38:00 AM
PolyPeptide Group Completes Acquisition Of Lonza Group (LZAGY.PK)'s Peptides Business And Operations In Braine-l'Alleud, Belgium 1/4/2017 10:42:51 AM
Lonza Group (LZAGY.PK) Concludes Divestment Of Peptides Business And Operations In Braine-l’Alleud, Belgium, To PolyPeptide 1/4/2017 8:27:46 AM
Lonza Group (LZAGY.PK) Clinches $5.5 Billion Deal for U.S. Drug Capsules Maker Capsugel 12/15/2016 5:56:04 AM
Lonza Group (LZAGY.PK) in Talks to By KKR's Capsugel in $5 Billion+ Deal 12/12/2016 6:09:04 AM
Lonza Group (LZAGY.PK) To Divest Peptides Business And Operations In Braine-l’Alleud, Belgium, To PolyPeptide 12/7/2016 10:11:13 AM
12345678910...
//-->